Showing 261 - 280 results of 71,549 for search '(( a n decrease ) OR ( 50 ((((ns decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.08s Refine Results
  1. 261
  2. 262
  3. 263
  4. 264
  5. 265
  6. 266
  7. 267
  8. 268
  9. 269

    BKM120 decreases cellular glycolytic metabolic activity in MB cell lines. by Ping Zhao (47228)

    Published 2017
    “…<p>MB cells were treated with BKM120 ranging from 31.25 nM to 4 μM over a course of 48 hours. ATP/cell assays showed a decrease in ATP level per cell after 48 hours of BKM120 treatment, which indicates a decrease in cellular glycolytic metabolic activity in MB cell lines in a dose-dependent manner. …”
  10. 270
  11. 271
  12. 272

    The MTT assay to determine decreases in residual cell viability in SK-N-BE2 and IMR-32 cells. by Nishant Mohan (474067)

    Published 2013
    “…As presented in the bar diagrams, combination of 50 nM LC3 shRNA plasmid and 25 µM GST in SK-N-BE2 cells while combination of 100 nM LC3 shRNA plasmid and 25 µM GST in IMR-32 cells showed the best synergistic efficacy, as determined by the combination index (CI) value, for the highest decrease in residual cell viability. …”
  13. 273
  14. 274

    DataSheet_2_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

    Published 2023
    “…Introduction<p>Our previous research has found that degradation of palmitoyltransferase in tumor cells using a linear peptide PROTAC leads to a significant decrease in PD-L1 expression in tumors. …”
  15. 275

    DataSheet_1_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

    Published 2023
    “…Introduction<p>Our previous research has found that degradation of palmitoyltransferase in tumor cells using a linear peptide PROTAC leads to a significant decrease in PD-L1 expression in tumors. …”
  16. 276
  17. 277
  18. 278
  19. 279
  20. 280